From: Impacts of dialysis adequacy and intradialytic hypotension on changes in dialysis recovery time
Parameter | Overall Mean (SD) or N (%) |
---|---|
Demographics: | |
Patient (n) | 98,616 (100%) |
Age (years) | 62.6 (14.4) |
Male (%) | 56,991 (57.8%) |
Race white (%) | 58,528 (69.1%) |
Non-Hispanic ethnicity (%) | 72,293 (87.6%) |
BMI (kg/m2) | 29.4 (9.2) |
Days from FDD to survey | 112 (26) |
Employed | 11,643 (15.3%) |
Comorbidities: | |
Number of comorbidities (n) | 1.92 (1.49) |
Diabetes (%) | 34,325 (34.8%) |
Ischemic Heart Disease (%) | 14,560 (14.8%) |
Congestive Heart Failure (%) | 16,377 (16.6%) |
Treatment Parameters: | |
HD start before 1200 h (%) | 65,876 (66.8%) |
UFV (L) | 2.16 (0.92) |
Normalized UFV by body weight (nUFVbw) (mL/kg) | 26.6 (10.8) |
UFR (mL/hour/kg) | 7.06 (2.92) |
HD treatment time (hours) | 3.82 (0.44) |
Number of treatments ±30 days of DRT survey (n) | 24.55 (3.92) |
Clinical Parameters: | |
Catheter (%) | 62,220 (64.7%) |
Pre-HD weight (kg) | 85.5 (23.7) |
Post-HD weight (kg) | 83.3 (23.3) |
IDWG (kg) | 2.21 (0.93) |
Treatments with IDH episodes (SBP < 100) per month (n) | 3.01 (3.32) |
Laboratories: | |
Pre-HD BUN (mg/dL) | 53.9 (16.6) |
Post-HD BUN (mg/dL) | 14.1 (5.7) |
Kt/V | 1.624 (0.318) |
Albumin (g/dL) | 3.67 (0.42) |
Sodium (mmol/L) | 137.9 (3.1) |
Potassium (mmoI/L) | 4.54 (0.55) |
Glucose (mg/dL) | 183.5 (88.0) |
Calcium (mg/dL) | 8.95 (0.60) |
Phosphate (mg/dL) | 5.21 (1.32) |
iPTH (pg/mL) | 386.5 (287.7) |
Hemoglobin (g/dL) | 10.83 (0.99) |
White blood cells (109/L) | 7.18 (2.51) |
Neutrophil to lymphocyte ratio | 4.21 (3.16) |